Related references
Note: Only part of the references are listed.Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions
A. Tolios et al.
DRUG RESISTANCE UPDATES (2020)
Dermatan sulfate epimerase 1 expression and mislocalization may interfere with dermatan sulfate synthesis and breast cancer cell growth
Eduardo Listik et al.
CARBOHYDRATE RESEARCH (2020)
ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells
Hana Jin et al.
CANCERS (2020)
NF-κB inhibitors in treatment and prevention of lung cancer
Rajan Radha Rasmi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Biological functions of lymphatic vessels
Tatiana V. Petrova et al.
SCIENCE (2020)
The Role of Endocan in Selected Kidney Diseases
Magdalena Nalewajska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia
Haili Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1
Fabian Haupt et al.
SCIENTIFIC REPORTS (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Textures of the tumour microenvironment
Julie S. Di Martino et al.
MECHANISMS OF CELL MIGRATION (2019)
Endovascular progenitors infiltrate melanomas and differentiate towards a variety of vascular beds promoting tumor metastasis
Prudence Donovan et al.
NATURE COMMUNICATIONS (2019)
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer
Hongzhou Cai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review)
Biaoxue Rong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells
Onur Bender et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Inflammation and cancer: What a surgical oncologist should know
Aurelien Dupre et al.
EJSO (2018)
The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma
Normann Steiner et al.
ANTICANCER RESEARCH (2018)
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
Nathalie De Freitas Caires et al.
CRITICAL CARE (2018)
Endocan as a prognostic biomarker of triple-negative breast cancer
Atsunobu Sagara et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Serum endocan levels in endometrial and ovarian cancers
Esra Laloglu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression
Wei-En Yang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma
Chung-Yu Lai et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
Liang-Yu Lin et al.
MEDICINE (2017)
Prognostic value of endocan in prostate cancer: clinicopathologic association between serum endocan levels and biochemical recurrence after radical prostatectomy
Burak Arslan et al.
TUMORI JOURNAL (2017)
Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer
Guo-Jun Lu et al.
ONCOTARGET (2017)
Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression
Chien-Min Chen et al.
ONCOTARGET (2017)
Prognostic value of endocan in prostate cancer: clinicopathologic association between serum endocan levels and biochemical recurrence after radical prostatectomy
Burak Arslan et al.
TUMORI JOURNAL (2017)
Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy
Xiaoyi Zheng et al.
PLOS ONE (2017)
Expressions of Endocan in Patients with Meningiomas and Gliomas
Pinar Atukeren et al.
DISEASE MARKERS (2016)
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments
Rong Biaoxue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion
Yanming Miao et al.
PITUITARY (2016)
Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression
Zhang Sumei et al.
TUMOR BIOLOGY (2016)
Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer
Yuan Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma
Chen Chen et al.
ONCOTARGET (2016)
The determination of serum and urinary endocan concentrations in patients with bladder cancer
Esra Laloglu et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas
Lin Cai et al.
ENDOCRINE (2016)
Endocan: A novel inflammatory indicator in cardiovascular disease?
Sevket Balta et al.
ATHEROSCLEROSIS (2015)
Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer
H. Jiang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor
Ahmed M. Abu El-Asrar et al.
CURRENT EYE RESEARCH (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability
Susana F. Rocha et al.
CIRCULATION RESEARCH (2014)
Endocan: A novel circulating proteoglycan
Arunava Kali et al.
INDIAN JOURNAL OF PHARMACOLOGY (2014)
Endocan, a new invasion and angiogenesis marker of pituitary adenomas
Fumihiro Matano et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Biological and clinical implications of endocan in gastric cancer
Wenyan Zhao et al.
TUMOR BIOLOGY (2014)
Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer
Zhongchuan Lv et al.
TUMOR BIOLOGY (2014)
Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer
Manal M. El Behery et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis
Filip Roudnicky et al.
CANCER RESEARCH (2013)
Expression and distribution of endocan in human tissues
S. M. Zhang et al.
BIOTECHNIC & HISTOCHEMISTRY (2012)
Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
Aurelie Cornelius et al.
BRAIN PATHOLOGY (2012)
ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer
Yun Hee Kang et al.
CELLULAR SIGNALLING (2012)
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma
Yun Hee Kang et al.
AMINO ACIDS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Experimental strategies for microRNA target identification
Daniel W. Thomson et al.
NUCLEIC ACIDS RESEARCH (2011)
Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer
Ni Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching
Geraldine A. Strasser et al.
BLOOD (2010)
Identification and functional analysis of endothelial tip cell-enriched genes
Raquel del Toro et al.
BLOOD (2010)
Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer
Na Young Ji et al.
CANCER SCIENCE (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan
Stephane Sarrazin et al.
GLYCOBIOLOGY (2010)
Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma
Xavier Leroy et al.
HISTOPATHOLOGY (2010)
Identification of Genes and Pathways Involved in Retinal Neovascularization by Microarray Analysis of Two Animal Models of Retinal Angiogenesis
Franco M. Recchia et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma
Geng-Wen Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Endocan Expression and Localization in Human Glioblastomas
Claude-Alain Maurage et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
The tumour microenvironment: a novel target for cancer therapy
E. Hanna et al.
ORAL DISEASES (2009)
Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis
Jay W. Shin et al.
BLOOD (2008)
Loss of Endocan tumorigenic properties after alternative splicing of exon 2
Florence Depontieu et al.
BMC CANCER (2008)
Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: Design and mechanism of action
Tahl Zimmerman et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Borrmann type IV: An independent prognostic factor for survival in gastric cancer
Ji Yeong An et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Correlation between expression and differentiation of endocan in colorectal cancer
Li Zuo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer
Emma Rennel et al.
EXPERIMENTAL CELL RESEARCH (2007)
Vascular endocan is preferentially expressed in tumor endothelium
Md. Ruhul Abid et al.
MICROVASCULAR RESEARCH (2006)
Endocan expression and relationship with survival in human non-small cell lung cancer
Bogdan Dragos Grigoriu et al.
CLINICAL CANCER RESEARCH (2006)
Hhex is a direct repressor of endothelial cell-specific molecule 1 (ESM-1)
Rong Cong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
S Sarrazin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Transforming growth factor-β-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells
RP Kirwan et al.
GLIA (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Identification of endothelial cell genes expressed in an in vitro model of angiogenesis:: Induction of ESM-1, βig-h3, and NrCAM
M Aitkenhead et al.
MICROVASCULAR RESEARCH (2002)
Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity
D Béchard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1
D Béchard et al.
JOURNAL OF IMMUNOLOGY (2001)
Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies
D Bechard et al.
JOURNAL OF VASCULAR RESEARCH (2000)
Expression and function of the homeodomain-containing protein Hex in thyroid cells
L Pellizzari et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
